Related Experiment Video
Updated: Jun 4, 2026

Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates
Published on: September 6, 2017
Weight changes and variability in the first week of life: associations with mortality in extremely preterm newborns
Serena Vigezzi1, Elad Resnick2, Enrico Vidal3
1Pediatric Nephrology Unit, Department of Women's and Children's Health, Padua University Hospital, Via Giustiniani 2, Padua, 35128, Italy. serenavigezzi@gmail.com.
Background:
In extremely preterm newborns (ELGANs, < 28 weeks' gestational age [GA]), early weight trajectories reflect fluid balance, yet thresholds for early risk stratification are lacking. We aimed to evaluate whether percentage weight change (ΔW%) from birth weight (BW) and week-1 weight variability were independently associated with death by postnatal day 7 and to identify clinically relevant thresholds.
Methods:
We performed a retrospective single-center secondary analysis of the Golden Week Program (University of Alabama at Birmingham NICU, 2014-2021). Newborns < 28 weeks' GA with BW ≥ 400 g and receiving active treatment were included; exclusion criteria were death ≤ 48 h, major congenital anomalies, or incomplete weight data. Multivariable logistic regression was performed, adjusted for GA, 5-min Apgar score, and BW z-score; optimal cutoffs were derived using the Youden Index.
Results:
Among 805 neonates, 55 (6.8%) died by day 7. Non-survivors had higher day-3 ΔW% than survivors (median - 5.3% vs. - 10.7%; p < 0.007). Day-3 ΔW% was independently associated with mortality (aOR 1.05; 95% CI 1.02-1.08), with an optimal cutoff of - 6.4% (sensitivity 57%, specificity 72%). Among variability metrics, total fluctuation (mean absolute day-to-day change in ΔW%) showed the best discrimination (aOR 1.45; 95% CI 1.29-1.65; AUC 0.84), with an optimal cutoff of 5.3% (sensitivity 76%, specificity 74%).
Conclusions:
ELGANs who do not lose 5-7% of BW by postnatal day 3 or exhibit an average day-to-day weight fluctuation > 5% of BW are at increased risk of early mortality. These weight-derived metrics may support early risk stratification but require prospective validation.
Related Concept Videos
Regression Toward the Mean
Pharmacokinetics in Pediatric Patients: Drug Distribution
